Search results for “Nogo Receptors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 214 patents, we discovered top 15 key players by total patent application. Biogen MA, Inc., Sirna Therapeutics, Inc., Novartis AG are dominant in this area. They take 92.99% of the total patent filing.
Massachusetts, United States
Patent: 113
California, United States
Patent: 8
Basel-Stadt, Switzerland
Patent: 7
Maharashtra, India
Patent: 6
Colorado, United States
Patent: 6
United States
Patent: 5
Austria
Patent: 5
Massachusetts, United States
Patent: 3
Osaka-fu, Japan
Patent: 3
New Jersey, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1 patents applied in the last 5 years. We discover 1 most active companies in this area.
undefined undefined
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1 patents in last 5 years, we discover 1 new entrants.
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 134 patents, we discovered top 5 universities and scientific research institutions by total patent application. Yale University, King's College London, University of Rochester are dominant in this area. They take 141.04% of the total patent filing.
Connecticut, United States
Patent: 117
United Kingdom
Patent: 8
New York, United States
Patent: 6
Hunan Sheng, China
Patent: 2
Hong Kong SAR, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: